Hercules Capital Inc. Preferred Stock 6.25% 10/30/33 is a preferred equity instrument issued by Hercules Capital Inc., a well-known business development company that specializes in venture lending. The primary function of this preferred stock is to provide investors with a fixed dividend yield, in this case, 6.25% annually, which is usually paid out quarterly. Preferred stockholders have a higher claim on assets and earnings than common shareholders, making it a more attractive option for those seeking stable income and priority in dividend distribution. This particular preferred stock is tied to the ongoing operations and financial health of Hercules Capital, which primarily invests in technology, life sciences, and sustainable and renewable technology companies. It plays a significant role in the market as it offers liquidity and flexibility to investors looking for exposure to high-growth sectors while maintaining a comparatively lower risk profile compared to common equity. The call date of 10/30/2033 indicates the timeframe in which the issuing company may choose to redeem the preferred shares, providing long-term planning options for both the issuer and investors.
United States
Hercules Capital (HTGC) has a fresh governance catalyst. The business appointed Alfred B. Fichera as an independent director and Audit Committee member on 17 September 2026, bringing extensive audit and asset management experience. Hercules Capital’s share price has softened in the short term, with the 30-day share price return down 3.26% and the year-to-date share price return down 10.34%. In contrast, the 1-year total shareholder return is slightly positive at 0.58% and the 5-year total...
Hercules Capital (HTGC) has agreed to provide NorthStar Medical Technologies with a multi-year growt
Based on the average brokerage recommendation (ABR), Hercules Capital (HTGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Hercules Capital (HTGC) closed the most recent trading day at $16.8, moving 1% from the previous trading session.
Hercules Capital (HTGC) closed at $16.97 in the latest trading session, marking a -1.45% move from the prior day.
Avoid TriplePoint Venture (TPVG): persistent underperformance, high non-accruals and weak dividend coverage threaten another cut by 2027. See more details here.
Investors talking about HCXY also mention
What share of all stock conversation is about HCXY?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% 0 | 0% +0 |
Of the messages about HCXY that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% | 100% 0 | 9.78% -90.22 | ||
| Bearish | 0% | 0% | 0% 0 | 90.22% +90.22 |
Of the messages about HCXY that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | 50% | 50% | 50% | 49.94% | ||
| Announcements | 0% | 0% | 0% | 0.02% | ||
| Controversies | 0% | 0% | 0% | 0% | ||
| Earnings | 0% | 0% | 0% | 0% | ||
| Macro | 50% | 50% | 50% | 50.04% | ||
| Technical Analysis | 0% | 0% | 0% | 0% |
Of the messages about HCXY, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 0.08% | ||
| Newcomers | 100% | 100% | 100% | 99.92% |